Morpholino

MO1-cpa6

ID

ZDB-MRPHLNO-101026-6

Name

MO1-cpa6

Previous Names

MO-2 (1)

Target

cpa6 (1)

Sequence

5' - AGAAAATAAGGGACTCACTGTCAAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking morpholino targets boundary of exon 2 and intron 2.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-cpa6

No data available

Phenotype

Phenotype resulting from MO1-cpa6

Phenotype	Fish	Figures
whole organism chga expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism slc1a2b expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism tac1 expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism cpa6 expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism edn1 expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism pcsk1nl expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism cpe expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism bdnf expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism npy expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism fosab expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism grin1a expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016
whole organism nts expression decreased amount, abnormal	WT + MO1-cpa6	Fig. 4 from Lopes et al., 2016

Phenotype of all Fish created by or utilizing MO1-cpa6

Phenotype	Fish	Conditions	Figures
whole organism chga expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism tac1 expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism pcsk1nl expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism npy expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism edn1 expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
swimming behavior process quality, ameliorated	WT + MO1-cpa6	chemical treatment: pentetrazol	Fig. 1 from Lopes et al., 2016
whole organism cpe expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism bdnf expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism fosab expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism grin1a expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
swimming behavior increased occurrence, ameliorated	WT + MO1-cpa6	chemical treatment: pilocarpine	Fig. 2 from Lopes et al., 2016
whole organism cpa6 expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism nts expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
whole organism slc1a2b expression decreased amount, abnormal	WT + MO1-cpa6	standard conditions	Fig. 4 from Lopes et al., 2016
swimming behavior increased occurrence, ameliorated	WT + MO1-cpa6	chemical treatment: pentetrazol	Fig. 1 from Lopes et al., 2016

Citations